Lennart Tonneijck

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Marcel H A Muskiet, Lennart Tonneijck, Mathijs C Bunck, Mark H H Kramer, D Margriet Ouwens, Bolette Hartmann, Jens J Holst, A H Jan Danser, Jaap A Joles, Daniël H van Raalte
Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trial. Diabetes, obesity & metabolism 24 (1) (2021)
Marcel H A Muskiet, Lennart Tonneijck, Mathijs C Bunck, D Margriet Ouwens, Jens Juul Holst, Alexander H J Danser, Daniël H van Raalte
Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial. Diabetes care 43 (11) (2020)
Lennart Tonneijck, Marcel H A Muskiet, Mark M Smits, Petter Bjornstad, Mark H H Kramer, Michaela Diamant, Ewout J Hoorn, Jaap A Joles, Daniel H van Raalte
Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials. Diabetes, obesity & metabolism 20 (5) (2018)
Lennart Tonneijck, Marcel H A Muskiet, Mark M Smits, Trynke Hoekstra, Mark H H Kramer, A H Jan Danser, Michaela Diamant, Jaap A Joles, Daniel H van Raalte
Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial. Diabetes, obesity & metabolism 19 (12) (2017)